Results: Eighty-six neonates were enrolled -45 no red light; 41 red light. There was no difference in severity of ROP (<27 weeks -p=0.463; ≥27 weeks -p=0.558) or requirement for laser treatment (<27 weeks -p=1.00; ≥27 weeks -no laser treatment in either group). Survival in the 670 nm red light treatment group was 100% (41/41) vs 89% (40/45) in untreated infants (p=0.057).
Background: Preconception care (PCC) defines health interventions prior to conception aimed at improving future pregnancy and infant outcomes. Our survey explored understanding and provision of PCC by General Practitioners (GPs) within the Sydney Local Health District.
Methods: A questionnaire developed in partnership with GPs assessed structure and content of PCC provided, attitudes towards PCC and perceived barriers and facilitators. Multiple strategies were used for dissemination including postal surveys, follow-up calls, e-newsletters and the Primary Health Network. The data was captured using REDCap research management system.
Results: 105 GPs completed the survey. 84% reported that GPs should be the main providers of PCC however only 53% were aware of PCC guidelines, with 70% aware of RACGP guidelines and 23% RANZCOG. 75% of respondents initiate PCC discussion with women of reproductive age, 56% provide PCC to women at higher risk of adverse outcomes and 16% wait for the discussion to be initiated by the patient. Smoking (87%), vaccination (85%), alcohol (84%) and medication use (82%) are the most discussed PCC components, while serology (90%), FBC (83%) and blood pressure (78%) are the most performed PCC assessments. Most respondents stated that PCC is essential for women with: preexisting diabetes (76%), previous pregnancy complications (71%) or chronic illness (70%). Only 45% stated PCC was essential for women >35 and 39% for overweight women.
Conclusions: GPs are key providers of PCC however; only half are aware of PCC guidelines. Improved resources and education are required to support adequate PCC provision. Background: Very preterm infants (born ≤30 weeks gestational age) are at risk of neurodevelopmental deficits including cognitive impairments. However accurate, early prognostication of these is challenging. This study investigates whether quantitative electroencephalography (QEEG) markers and/or diffusion magnetic resonance imaging (dMRI) acquired at term equivalent age can predict cognitive functions at 12 months of age.
USING EEG AND MRI AT TERM EQUIVALENT AGE IN VERY PRETERM INFANTS TO PREDICT COGNITIVE OUTCOME
Methods: 79 very preterm infants without any major congenital/chromosomal abnormalities were studied. EEG and MRI were recorded at term equivalent age. QEEG measures (relative power and coherence) were computed for delta (0.5-2Hz), theta (2-6 Hz), alpha (6-13 Hz), and beta (13-30 Hz) frequency bands at seven fronto-central electrodes. dMRI measures (fractional anisotropy, FA and mean diffusivity, MD) of corpus callosum (CC) were also computed. Cognitive function was assessed at 12 months corrected age using Bayley Scales of Infant and Toddler Development (3 rd edition). Linear regression was used to determine whether QEEG and/or dMRI measures can predict cognitive composite scores.
Results: FA was significantly, positively associated with cognitive scores (B: 161.25, 95% CI: 60.63-261.87, R Square: 0.12, p<0.01). In contrast, MD was significantly, negatively associated with cognitive composite scores (B: -61083.35, 95% CI: -112382.53--9784.17, R Square: 0.07, p<0.05) . No significant association was found between QEEG measures and cognitive scores.
Conclusions: These results suggest that at term equivalent age in very preterm infants, corpus callosum dMRI measures (both FA and MD) may predict cognitive function at 12 months of age. These measures could potentially help predict cognitive outcomes and identify at-risk preterm infants. 
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